MIT Research
Scientists from MIT and Harvard have developed engineered CAR-NK immune cells that evade the body's defenses to target cancer effectively. This advancement could enable off-the-shelf treatments available immediately after diagnosis, bypassing weeks of personalized cell production. The cells showed strong results in mouse tests, destroying most lymphoma cells without triggering severe side effects.
由 AI 报道
Researchers at MIT have improved prime editing, a gene-editing technique, to make it 60 times more accurate by minimizing unintended DNA mutations. This advancement could enhance the safety of treatments for genetic diseases. The study, led by Vikash Chauhan, was published in Nature.